27
Participants
Start Date
April 2, 2024
Primary Completion Date
June 15, 2026
Study Completion Date
December 30, 2026
autologous FL-33 CAR T therapy
Autologous FL-33 CAR T cells are infused intravenously.
prior-HSCT donor-derived FL-33 CAR T therapy
Prior-HSCT donor-derived FL-33 CAR T cells are infused intravenously.
Newly matched donor-derived FL-33 CAR T therapy
Newly matched donor-derived FL-33 CAR T cells are infused intravenously
NOT_YET_RECRUITING
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, Shanghai
NOT_YET_RECRUITING
Shanghai Liquan Hospital, Shanghai
NOT_YET_RECRUITING
The General Hospital of Western Theater Command PLA, Chengdu
RECRUITING
BeijingGoBroadH, Beijing
The General Hospital of Western Theater Command
OTHER
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai
OTHER
Shanghai Liquan Hospital
OTHER
Beijing GoBroad Hospital
OTHER